| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.17 | 0.004 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.005 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.097 | 0.005 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.085 | 0.005 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.092 | 0.005 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.005 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.006 |